Results 161 to 170 of about 9,770,479 (402)
Local anesthetics: hydrophilic and hydrophobic pathways for the drug-receptor reaction. [PDF]
Bertil Hille
openalex +1 more source
In over 50% of non‐metastatic breast cancer patients, circulating tumor cells (CTCs) along the whole epithelial‐mesenchymal transition spectrum are detected. Total CTC number and individual phenotypes relate to aggressive disease characteristics, including lymph node involvement and higher tumor proliferation. At the single‐cell level, mesenchymal CTCs
Justyna Topa +14 more
wiley +1 more source
Epidemiological Studies of Adverse Drug Reactions
Larry G. Seidl +2 more
openalex +2 more sources
Ocular reaction to propranolol and resolution on continued treatment with a different beta-blocking drug. [PDF]
R B Cubey, S. H. Taylor
openalex +1 more source
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece +18 more
wiley +1 more source
Cutaneous reactions with enfortumab vedotin: A case series and review of the literature
Allison S. Dobry, MD +6 more
doaj +1 more source
Survivin and Aurora Kinase A control cell fate decisions during mitosis
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir +2 more
wiley +1 more source
GENERALIZED LYMPHADENOPATHY AS A DRUG REACTION TO HYDANTOIN
Alf Björnberg, R Holst
openalex +1 more source

